coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Taba Wigan PCN, Wigan (LAD) · Health Inequalities Profile

    PCN U30170 · NHS Greater Manchester Integrated Care Board · 11 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    57,149

    Registered population

    60.3% aged 18–64

    18.8%

    Aged 65+

    ICB 14.9% · England 17.9%

    21.2%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~17,364

    Core20 residents (est.)

    Resident basis; registered basis ~12,148 · see page 3

    9,377

    Hypertension register

    +8.42% in 3 yrs · England +5.60%

    518

    SMI register

    14.5% of Wigan (LAD)'s

    1,423

    COPD register

    Reviews -0.70% in 3 yrs

    Forecast to 2030

    11,487

    Hypertension patients, 2030

    +2,110 on today

    78.5%

    QRISK ≥20% on statins, 2030

    +5.76pp over 3 yrs

    4.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    10.2 pp
    Pre-school MMR second dose and booster drop-off.

    Age-five MMR coverage drops 10.2 pp from dose 1 (97.2%) to dose 2 (87.0%), matching 4-in-1 boosters (87.0%, 8 pp below the 95.0% target).

    -11.4%
    Heart failure reviews falling behind England.

    Heart failure annual reviews fell 11.4% over 2023 to 2025 (England +8.7%) to 71.0% (England 78.5%), while asthma leaves a 1,448-patient unreviewed scale.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    TABA WIGAN PCN serves 57,149 patients with 18.8% aged 65 and over

    TABA WIGAN PCN serves 57,149 registered patients. Patients aged 65 and over comprise 18.8% (10,740 patients), in line with Wigan (LAD) at 18.8%, and above NHS Greater Manchester Integrated Care Board (14.9%) and England (17.9%). Children aged 0-17 represent 20.9% (11,924 patients), compared with 20.0% in Wigan (LAD), 21.8% in the ICB and 19.6% in England. Gypsy or Irish Traveller and Roma residents each represent 0.1% of usual residents. Projected list growth to 2030 is 2.0% (Wigan 1.1%, ICB 1.6%, England 2.3%) under unverified methods. Registered counts lack supplied observation periods.

    Age profile

    0–1720.9%
    18–6460.3%
    65+18.8%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Wigan (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wigan LA)2,7062,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)63.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wigan LA)1,2431,0219552024/25
    Falls deaths, all ages, per 100,000 (Wigan LA)12.318.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation matches England overall but spans 41.0 percentage points across practices

    The PCN Core20 share is 21.2%, below Wigan (29.4%) and NHS Greater Manchester ICB (40.7%), and in line with England (21.0%). Across practices, shares span a 41.0 pp range: Poplar Street Surgery records 41.0% (2,343 estimated patients), while Sivakumar & Partner, Boothstown Medical Centre, and Dr Vardhan's Surgery each record 0.0%. Dr Kk Chan & Partners has the largest volume at 2,940 estimated patients (33.2%). Practice estimates sum to 12,148 registered patients versus 17,364 resident decile 1 and 2 individuals, so outreach must balance concentration against volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Poplar Street41.0% · 2,343 patients
    Dr Vasanth38.7% · 680 patients
    Dr Kk Chan &33.2% · 2,940 patients
    Meadowview32.9% · 2,221 patients
    Bee Fold31.6% · 1,205 patients
    Tyldesley31.4% · 1,453 patients
    Elliott Street24.9% · 1,173 patients
    Astley General3.0% · 133 patients
    Sivakumar &0.0% · 0 patients
    Boothstown0.0% · 0 patients
    Dr Vardhan's0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    518

    SMI register

    0.91% recorded prevalence

    346

    Learning disability register

    0.61% recorded prevalence

    11

    Care homes, 327 beds

    In the PCN catchment

    10.1%

    Provide unpaid care

    Wigan (LAD), Census 2021

    The PCN records 518 SMI patients (0.9% vs Wigan 1.0%, ICB 1.1%, England 1.0%) and 346 learning disability patients (0.6% vs Wigan 0.7%, ICB 0.6%, England 0.6%). Catchment care homes comprise 327 beds across 11 sites. Borough figures record 11 rough sleepers (2025) and 10.1% unpaid care, not extrapolatable to PCN lists.

    Severe mental illness: physical health checks

    SMI prevalence is 0.9% (518 patients). Recorded checks reached 87.7% for blood pressure (England 83.4%), 89.5% for BMI (England 82.1%), and 87.0% for alcohol (England 81.8%). Uncaptured check elements mean full physical check completion cannot be confirmed.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,377

    Hypertension register

    +8.42%

    Register growth, 3 yrs

    Wigan (LAD) +10.59% · England +5.60%

    +3.86pp

    BP control, under 80

    ≤140/90 · +6.51pp aged 80+

    +2,110

    More patients by 2030

    Forecast 11,487 (19.39%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 16.5% (9,377 patients), which sits above England (15.2%) and NHS Greater Manchester ICB (14.4%), but trails Wigan (LAD) at 18.0%. Crude register modelling indicates a scenario gap of 934 patients against the borough benchmark, though this is not age-adjusted and does not confirm undiagnosed disease. Blood pressure checks reach 91.2% (England 90.0%), and 76.5% are treated to target, exceeding Wigan (75.6%), the ICB (71.4%) and England (70.3%). Trailing borough prevalence may reflect age structure or case-finding differences, testable by practice audit.

    Lipids and statins

    Among diabetic patients without cardiovascular disease, statin coverage is 70.2%, trailing Wigan (72.5%), England (73.2%) and NHS Greater Manchester ICB (75.7%). Therapy for QRISK ≥ 20% reaches 65.2% (England 63.6%). Lower primary prevention statin coverage highlights an opportunity to review prescribing for at-risk diabetic patients.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202698,709£2.20£1.94£1.86£217,160
    Cardiovascular (all), 2025131,864£3.79£3.15£3.33£499,765

    In 2026, the PCN prescribed 98,709 lipid-modifying items at £2.20 per item, compared with £2.09 in Wigan (LAD), £1.94 in NHS Greater Manchester ICB and £1.86 in England. This represents £33,561 more than at England's unit cost. Higher unit costs indicate an opportunity to review prescribing choices to align with ICB and national benchmarks.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +1.22%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.78%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 8.1% (4,313 patients; England 6.6%), with prescribing of 2,478 items per 1,000 aged 5-19 (England 1,488). Annual reviews reached 66.4% (England 65.7%), leaving a scale of 1,448 unreviewed patients. COPD prevalence is 2.5% (1,423 patients; Wigan 2.6%), but the register fell 0.6% over 2023 to 2025 while Wigan (LAD) grew +6.2% and England +2.6%. While COPD reviews reached 79.8% (England 76.4%), the contracting register could reflect diagnostic or case-finding differences, testable by practice audit.

    Cancer register and children's immunisation

    The cancer register grew +11.5% over 2023 to 2025 to 2,258 patients (4.0% prevalence; England 3.8%). In Q1 2025/26, age-5 MMR dose 1 reaches 97.2% (England 91.7%), but dose 2 drops 10.2 pp to 87.0%, matching the 4-in-1 booster at 87.0% (both 8 pp below the 95.0% target across 177 children). This drop-off could reflect recall timing gaps, testable by checking practice reminder logs.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.5%

    England 91.0%

    6-in-1 complete primary course at 24 months96.0%

    England 92.2%

    MMR dose 1 at 24 months93.3%

    England 88.3%

    MMR dose 2 at age 587.0%

    England 82.8%

    4-in-1 pre-school booster at age 587.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, NHS Greater Manchester ICB recorded 55.6% of staged cancers diagnosed at stage 1 or 2 (6,491 of 11,679 known-stage cases; England 55.3%), sitting 19.4 pp below the 75.0% national ambition by 2028. Known stage was recorded for 70.8% of 16,492 registered cancers (England 67.0%). Early-stage share rose +3.1 pp from 52.4% in 2013, leaving an ICB scale gap of about 2,270 extra early diagnoses annually. System staging reflects regional diagnostics, not PCN performance. In TABA WIGAN PCN, cervical screening reached 75.2% (England 66.8%), though screening reached 66.2% at Elliott Street Surgery and 66.3% at The Surgery, Tyldesley.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Bolton NHS Foundation Trust, 69.66% of patients met the 62-day referral to treatment standard, sitting 15.3 pp below the 85.0% standard. For the 28-day faster diagnosis standard, Bolton achieved 80.48% (distance 5.5 pp to the 75.0% standard) and met the 31-day combined standard at 96.50% (standard 96.0%, distance 0.5 pp). Across NHS Greater Manchester ICB, the 62-day standard reached 75.73% (sitting 9.3 pp below the 85.0% standard), while 28-day faster diagnosis achieved 79.53% (distance 4.5 pp) and the 31-day standard was 96.49% (distance 0.5 pp).

    Pathways within standard (%)BoltonManchesterNorthern Care AllianceGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4880.0675.2079.5379.32
    31-day treatment (96%)96.5092.5494.5496.4992.50
    62-day referral to treatment (85%)69.6672.8578.6575.7371.16
    Diagnostic waits over 6 weeks (%)BoltonManchesterNorthern Care AllianceEngland
    MRI2.0511.685.0921.40
    CT19.4014.664.109.92
    Echocardiography3.484.9131.4828.48
    Colonoscopy1.334.5140.0430.83
    Gastroscopy2.0629.3536.4829.02
    All 15 DM01 tests15.788.9815.7123.14
    Community services activityWigan residentsGreater Manchester ICB
    Care contacts48,150573,310
    Referrals13,75094,470
    Patients with a contact18,695183,535

    Community services (residents of Wigan), Jun 2026 (provisional). In the Community Services Dataset for June 2026 (provisional), adults aged 65 and over accounted for 58.5% of community service contacts among borough residents, representing 28,190 of 48,150 total contacts. Activity is reported at local authority level rather than PCN or provider level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, QOF vaccination and immunisation domain achievement spanned 41.7 pp across practices, from 43.8% at Dr Vasanth to 85.5% at Bee Fold Medical Centre (England 55.2%). In contrast, clinical-domain achievement reached 96.9% to 100.0%. This variation could reflect practice-level call-recall and access differences, though this has not been confirmed locally.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Meadowview Surgery10632.989.0%76.2%91.6%
    Sivakumar &1270.087.6%78.9%89.4%
    Astley General883.073.4%88.1%88.5%
    Elliott Street10424.976.1%82.6%86.1%
    Poplar Street10641.077.3%82.3%86.0%
    Dr Kk Chan &11033.266.4%72.8%85.1%
    Dr Vardhan's1080.081.8%74.1%82.5%
    Bee Fold10831.684.4%80.2%80.9%
    Tyldesley10831.475.2%77.4%78.4%
    Dr Vasanth8338.768.8%63.6%73.7%
    Boothstown980.045.3%65.0%68.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWigan (LAD)AssetPCNWigan (LAD)
    Care homes (catchment)11 (327 beds)n/aSchools (catchment)69n/a
    Children's centres420Places of worship29164
    Libraries210Primary schools (LA maintained)1768
    Primary academies321Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Pre-school MMR2 and booster recall

    In Q1 2025/26 across 177 children aged 5, MMR dose 2 and the 4-in-1 booster both reached 87.0%, 10.2 pp below MMR dose 1 (97.2%). For discussion, practices could audit age-five call-recall lists, synchronise MMR2 and 4-in-1 invitations, and offer flexible pre-school clinic slots. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Asthma annual review and prescribing recall

    Asthma prevalence is 8.1% (4,313 patients; England 6.6%) with 66.4% reviewed in 12 months (England 65.7%), leaving a scale of 1,448 unreviewed patients. For discussion, the PCN could run a single-template asthma recall combining annual review with inhaler checks, prioritising Core20 practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Targeted hypertension case-finding audit

    Recorded hypertension prevalence is 16.5% (9,377 patients), above England (15.2%, -673 scenario) but below Wigan (18.0%), a crude gap of up to 934 patients. For discussion, practices could search records for repeated raised BP readings without a hypertension code and offer opportunistic checks in Core20 practices. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Differentiated Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Targeted hypertension case finding (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Pre-school MMR2 and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Asthma annual review and prescribing recall (p12)Asthma register · Asthma: QOF prevalence · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 3 · Targeted hypertension case-finding audit (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15